D-0398-2025 Class II Ongoing

Recalled by American Regent, Inc. — New Albany, OH

FDA drug recall D-0398-2025 was initiated by American Regent, Inc. on Apr 18, 2025 and is designated Class II. Reason for recall: Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance. The recall status is ongoing. Affected quantity: 29,777 (cartons of 10 x 10mL vials).

Recall details

Product Type
Drugs
Report Date
May 7, 2025
Initiation Date
Apr 18, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
29,777 (cartons of 10 x 10mL vials)

Product description

niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 mL Single Dose Vial, Rx Only, Mfd for: Civica, Inc., Lehi, UT 84043,Mfd by: American Regent, Inc., New Albany, OH 43064. NDC Carton: 72572-470-10/ NDC Vial: 72572-470-01.

Reason for recall

Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.

Distribution pattern

Nationwide in the USA

Code information

Lots, expiry: Lot 24025N0C0, 6/30/2025; Lot 24115N0C0, 10/31/2025; Lot 24116N0C0, 3/31/2026; Lot 24160N0C0, 12/31/2025; Lot 24217N0C0, 01/31/2026; Lot 24288N0C0, 04/30/2026; Lot 24331N0C0, 5/31/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0398-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0398-2025. Report a data issue: hello@regdatalab.com.